EP3452462A4 - Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé - Google Patents

Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé Download PDF

Info

Publication number
EP3452462A4
EP3452462A4 EP17792622.7A EP17792622A EP3452462A4 EP 3452462 A4 EP3452462 A4 EP 3452462A4 EP 17792622 A EP17792622 A EP 17792622A EP 3452462 A4 EP3452462 A4 EP 3452462A4
Authority
EP
European Patent Office
Prior art keywords
benzimidazol
ethoxyethyl
piperidinyl
phenyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17792622.7A
Other languages
German (de)
English (en)
Other versions
EP3452462A1 (fr
Inventor
Srinivasan Thirumalai Rajan
Sajja Eswaraiah
Ghojala Venkat Reddy
Sagyam RAJESHWAR REDDY
Singavarapu ADILAKSHMI
Boge RAJESHAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSN Laboratories Pvt Ltd
Original Assignee
MSN Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MSN Laboratories Pvt Ltd filed Critical MSN Laboratories Pvt Ltd
Publication of EP3452462A1 publication Critical patent/EP3452462A1/fr
Publication of EP3452462A4 publication Critical patent/EP3452462A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP17792622.7A 2016-05-05 2017-05-02 Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé Withdrawn EP3452462A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201641015655 2016-05-05
PCT/IN2017/000099 WO2017191651A1 (fr) 2016-05-05 2017-05-02 Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé

Publications (2)

Publication Number Publication Date
EP3452462A1 EP3452462A1 (fr) 2019-03-13
EP3452462A4 true EP3452462A4 (fr) 2019-10-23

Family

ID=60202837

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17792622.7A Withdrawn EP3452462A4 (fr) 2016-05-05 2017-05-02 Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé

Country Status (2)

Country Link
EP (1) EP3452462A4 (fr)
WO (1) WO2017191651A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020065475A1 (fr) * 2018-09-25 2020-04-02 Glenmark Life Sciences Limited; Glenmark Pharmaceuticals Limited Procédé pour la préparation de bilastine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447682A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 比拉斯汀化合物
EP3327012A1 (fr) * 2015-07-24 2018-05-30 Disproquima, S.A. Formes cristallines de la bilastine et procédés pour leur préparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124167B1 (es) * 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
SK288052B6 (sk) * 2002-04-19 2013-03-01 Faes Farma, S.A. Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it
WO2009102155A2 (fr) * 2008-02-12 2009-08-20 Yuhan Corporation Processus de préparation de dérivés d'acide 2-méthyl-2´-phénylpropionique et nouveaux composés intermédiaires
CZ307500B6 (cs) * 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447682A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 比拉斯汀化合物
EP3327012A1 (fr) * 2015-07-24 2018-05-30 Disproquima, S.A. Formes cristallines de la bilastine et procédés pour leur préparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"SYNTHESIS AND CRYSTALLINE FORMS OF BILASTINE", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 23 September 2016 (2016-09-23), XP013172874, ISSN: 1533-0001 *
See also references of WO2017191651A1 *

Also Published As

Publication number Publication date
EP3452462A1 (fr) 2019-03-13
WO2017191651A1 (fr) 2017-11-09

Similar Documents

Publication Publication Date Title
IL257390B (en) Salts of 1-((4-methoxymethyl)-4-(((s2,r1)-2-phenyl-cyclopropylamine)methyl)piperidine-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitors
HK1247201A1 (zh) 2-(5-(3-氟苯基)-3-羥基吡啶甲醯胺)乙酸的固體形式、其組合物及用途
DK2501692T3 (da) Fremgangsmåde til fremstilling af dabigatranetexilat
WO2014188453A3 (fr) Nouveau procédé de préparation de l'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl) phényl]-2-méthylpropanoïque
SG11201600996UA (en) Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
EP3307722A4 (fr) Formes solides d'acide (z)-4-(5- ((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidène) méthyl)furanne-2-yl) benzoïque
EP3399979A4 (fr) Formulations de 2-(4-chlorophényl)-n-((2-(2,6-dioxopipéridin-3-yl)-1-oxoisoindolin-5-yl)méthyl)-2,2-difluoroacétamide
HK1217479A1 (zh) -取代的氧- -二硝基-苯基 -氧-丙酸酯的化合物，方法及其應用
EP3207928A4 (fr) Préparation composite, contenant un nouveau dérivé de l'acide 3-(4- (benzyloxy)phényl)hex-4-inoïque et un autre principe actif, et destinée à prévenir ou traiter les maladies métaboliques
DK3227273T3 (da) Sammensætninger, som omfatter 2-((1-(2(4-fluorphenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-on, til behanlding af skizofreni
WO2013150545A8 (fr) Procédés de préparation de dérivés de benzimidazole et de sels de ceux-ci
EP3174537A4 (fr) Isoxazolines monocycliques utilisées comme inhibiteurs de la protéine de transfert des esters de cholestérol
DK2763981T3 (da) Fremgangsmåde til fremstilling af 1-(4-(4-(3,4-dichlor-2-fluorphenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-on-hydrochlorid og mellemprodukter anvendt deri
HK1195559A1 (zh) -{ }- -{ -三氟乙氧基 -苯並異噁唑- 氧}甲基 哌啶- 甲基}-四氫- -吡喃- -羧酸的多晶型物
ZA202003028B (en) Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
IL263786B (en) Crystalline forms of 4-(5-(7,4-dimethylbenzofuran-2-yl)-4,2,1-oxadiazol-3-yl)benzoic acid and processes for their preparation
EP3302466A4 (fr) Composés 3- (phényl)-n- (4-phénoxybenzyl) -1,2,4-oxadiazole-5-carboxamide pour la prise en charge de maladies médiées par la protéine cftr
EP3452462A4 (fr) Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé
EP3546441A4 (fr) Procédé de préparation d'acide acrylique et d'acrylate de méthyle
EP3233824A4 (fr) Compositions de (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-méthyl-1h-1,2,4-triazol-3-yl)phényl)-3,6-dihydropyridin-1 (2h)-yl)-2-oxoéthyl)-3-(méthylthio)pyrrolidine -3-carboxamide pour préparations pharmaceutiques
PT2943488T (pt) Formas de sal de meglumina do ácido 2-((1r,4r)-4-(4-(5- (benzoxazol-2-ilamina)piridin-2-il)fenil)ciclohexil) acético e sua utilização como inibidores de dgat1
RS58961B1 (sr) Proces proizvodnje 2-[4-(ciklopropankarbonil)fenil]-2-metil-propannitrila
IL249248A0 (en) Non-aqueous crystalline form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-2,1-benzaisoxazole
EP3233079A4 (fr) Compositions de (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-méthyl-1h-1,2,4-triazol-3-yl)phényl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoéthyl)-3- (méthylthio)pyrrolidine-3-carboxamide pour préparations pharmaceutiques
EP3345898A4 (fr) Cristaux d'acide 5-cyclopropyl-2-((1-(3-fluorobenzyl)-1h-indol-5-yl)amino)nicotinique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190919

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 235/14 20060101ALI20190914BHEP

Ipc: C07D 235/08 20060101ALI20190914BHEP

Ipc: C07D 211/62 20060101ALI20190914BHEP

Ipc: C07D 401/04 20060101AFI20190914BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210727